Stevanato Group S.p.A. (NYSE:STVN) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Stevanato Group S.p.A. (NYSE:STVN) have received a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company.

A number of equities research analysts have issued reports on the company. Bank of America raised their target price on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, December 13th. Wolfe Research started coverage on Stevanato Group in a research note on Friday, December 13th. They set an “outperform” rating and a $28.00 target price on the stock. UBS Group decreased their price target on Stevanato Group from $24.00 to $23.50 and set a “neutral” rating for the company in a research note on Friday, March 7th. Morgan Stanley reissued an “equal weight” rating and set a $23.00 price target (down from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Finally, William Blair reiterated an “outperform” rating on shares of Stevanato Group in a research report on Friday, March 7th.

Stevanato Group Trading Down 0.3 %

Stevanato Group stock opened at €20.25 ($22.01) on Friday. Stevanato Group has a 1 year low of €16.56 ($18.00) and a 1 year high of €32.98 ($35.85). The firm’s 50-day moving average is €20.90 and its 200-day moving average is €20.59. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. The company has a market cap of $6.13 billion, a P/E ratio of 43.09, a PEG ratio of 7.18 and a beta of 0.60.

Stevanato Group (NYSE:STVN) last issued its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of €0.20 ($0.22). The firm had revenue of €352.68 million for the quarter, compared to analysts’ expectations of €346.26 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. On average, equities analysts expect that Stevanato Group will post 0.5 earnings per share for the current year.

Institutional Investors Weigh In On Stevanato Group

Hedge funds and other institutional investors have recently bought and sold shares of the business. Natixis Advisors LLC grew its stake in shares of Stevanato Group by 20.3% in the 3rd quarter. Natixis Advisors LLC now owns 51,343 shares of the company’s stock worth $1,027,000 after purchasing an additional 8,669 shares during the last quarter. Raymond James Trust N.A. grew its position in Stevanato Group by 22.6% in the third quarter. Raymond James Trust N.A. now owns 12,556 shares of the company’s stock worth $251,000 after buying an additional 2,317 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in Stevanato Group by 16.9% in the third quarter. The Manufacturers Life Insurance Company now owns 294,235 shares of the company’s stock worth $5,885,000 after buying an additional 42,629 shares during the last quarter. Hardy Reed LLC lifted its position in shares of Stevanato Group by 8.2% during the 3rd quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock valued at $222,000 after acquiring an additional 840 shares during the last quarter. Finally, Glenmede Trust Co. NA boosted its stake in shares of Stevanato Group by 12.7% during the 3rd quarter. Glenmede Trust Co. NA now owns 35,941 shares of the company’s stock worth $719,000 after acquiring an additional 4,050 shares in the last quarter.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.